Is Sermorelin actually better than GHRP-2, GHRP-6, and Hexarelin

Ever stood in front of four GH-peptide vials wondering which one actually deserves your fridge space? Short answer: sermorelin is the gentlest, best-proven pick for most people, but GHRP-2, GHRP-6, and Hexarelin each earn their spot for a specific job sermorelin can't do.

Folks assume "GH peptide" is one category, like there's a single winner and everybody else is a consolation prize. Nope. That is NOT how it works. I get some version of this question constantly, and the honest answer takes a little unpacking.

The honest split: what each one is actually built to do

Sermorelin is a GHRH peptide. It works upstream, tapping your pituitary's own GHRH switch so YOUR body makes the GH pulse, with the natural dimmer switch (somatostatin) still attached. Gentle. Physiologic. Boring, in the best way.

GHRP-2, GHRP-6, and Hexarelin are a different animal. All three hit the ghrelin receptor instead of the GHRH receptor, and all three bring baggage sermorelin doesn't: a cortisol bump, a prolactin bump, and, for GHRP-6 especially, a hunger signal that has you raiding the fridge 20 minutes after you pin. Sermorelin plays it straight. GHRP-2, GHRP-6, and Hexarelin play it loud.

Here's the part that actually surprised me the first time I dug into this. One of the better human data points we have on this whole class comes from a study where sermorelin, GHRP-2, and GHRP-6 were given together to hypogonadal men, not pitted against each other. So a lot of the "which one wins" framing you see online is, frankly, made up. Nobody's run the clean three-arm human trial. I wish they had.

Evidence quality: where the paper trail actually holds up

This is where sermorelin pulls ahead, and it's not close.

Sermorelin has actual randomized controlled trials, in growth-deficient kids, showing real height-velocity gains. A large open-label multicenter trial found growth velocity roughly DOUBLED on sermorelin versus no treatment. That's not a forum anecdote. That's an FDA-dossier-grade result, from back when sermorelin was an approved drug called Geref.

GHRP-2, GHRP-6, and Hexarelin don't have anything close to that. Their human data is REAL, and they do raise GH. But it's mostly short dosing studies measuring a GH spike over a few hours, not long-run outcome trials the way sermorelin has.

Does the ghrelin-receptor trio work? You bet. Is it proven the way sermorelin is proven? Nope. Different question entirely.

The safety picture tells a similar story. Sermorelin's pediatric trials tracked side effects closely, things like injection-site reactions, flushing, occasional headache, generally mild. Decades of real-world use as Geref back that up further. There is NOTHING like that track record behind the other three yet.

Cost and side-effect load: what you're actually signing up for

Let's talk money and misery, because both matter here.

Sermorelin is cheap, mild, and forgiving. You dose it at night, fasted, and mostly feel nothing except maybe better sleep a few weeks in. Low drama.

GHRP-2 costs you more attention, not necessarily more dollars, because you're managing a stronger GH pulse plus a moderate cortisol and prolactin bump. GHRP-6 adds intense, fast-onset hunger on top of that, the kind that hits inside 20 minutes and has real clinical use for hard gainers, but it's a damn nuisance if you're trying to lean out. Hexarelin is the heaviest hitter of the three: the strongest GH pulse in the class, the most prolactin baggage, and a desensitization clock that starts ticking around week eight. Run it too long and you're just paying for side effects with nothing left in the tank.

Here's an analogy I use constantly with clients chasing the flashiest new compound before they've nailed the basics: you don't hang crown molding in a house with no foundation. Sermorelin IS the foundation, the everyday GH-axis support most people should build first. GHRP-2, GHRP-6, and Hexarelin are the crown molding: impressive, situational, and honestly wasted if the foundation underneath isn't solid.

Who each one actually suits

Sermorelin fits nearly everybody chasing sleep quality, recovery, and a gentle nudge to GH and IGF-1. It's the default, and for good reason.

GHRP-2 fits someone who's already run a GHRH peptide, wants a bigger GH lever, and is willing to track cortisol and prolactin for it.

GHRP-6 fits a narrow lane: hard gainers and post-surgical patients who genuinely need the appetite boost as therapy, not as an accident.

Hexarelin fits short, aggressive cycles, the kind where an eight-week ceiling actually matches how long you planned to run it anyway. It's a poor fit for anyone wanting a daily, years-long GH-axis habit.

The disclaimer, and real-world numbers

Now the part my lawyer makes me say, and honestly he's right:

The doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

The trial dose behind sermorelin's pediatric data was 30 mcg/kg at bedtime. The protocol most adults actually run is 200 to 300 mcg subcutaneously, nightly, on an empty stomach, about five nights a week. GHRP-2 typically runs 100 to 200 mcg, once or twice daily. GHRP-6 tends to sit around 100 mcg, two to three times daily, timed around meals because the hunger hits fast. Hexarelin usually runs 100 to 200 mcg, once or twice daily, for no more than four to eight weeks before a real break. Reconstitution math and injection basics are covered in the how-to-inject guide if you need the step-by-step.

So which one's "better"? Depends what you mean. Best proof, safest track record, gentlest ride: sermorelin, hands down. Biggest GH spike for a short, specific job: one of the other three, picked on purpose, not by accident. That's the whole game.

Thanks for reading. In health, Rick Gold.